Perrin S. Baker
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Small Molecule Inhibition of an Exopolysaccharide Modification Enzyme is a Viable Strategy To Block Pseudomonas aeruginosa Pel Biofilm Formation.
Journal: Microbiology spectrum
Published: April 26, 2023
Preclinical Evaluation of Recombinant Microbial Glycoside Hydrolases as Antibiofilm Agents in Acute Pulmonary Pseudomonas aeruginosa Infection.
Journal: Antimicrobial agents and chemotherapy
Published: July 21, 2022
Distinct types of multicellular aggregates in Pseudomonas aeruginosa liquid cultures.
Journal: NPJ biofilms and microbiomes
Published: June 24, 2022
Molecular mechanism of Aspergillus fumigatus biofilm disruption by fungal and bacterial glycoside hydrolases.
Journal: The Journal of biological chemistry
Published: March 24, 2019
Treatment with the Pseudomonas aeruginosa Glycoside Hydrolase PslG Combats Wound Infection by Improving Antibiotic Efficacy and Host Innate Immune Activity.
Journal: Antimicrobial agents and chemotherapy
Published: February 01, 2019
PgaB orthologues contain a glycoside hydrolase domain that cleaves deacetylated poly-β(1,6)-N-acetylglucosamine and can disrupt bacterial biofilms.
Journal: PLoS pathogens
Published: October 20, 2017
Microbial glycoside hydrolases as antibiofilm agents with cross-kingdom activity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 22, 2017
Thrombomodulin Expression in Tissues From Dogs With Systemic Inflammatory Disease.
Journal: Veterinary pathology
Published: March 02, 2016
Functional genetics-directed identification of novel pharmacological inhibitors of FAS- and TNF-dependent apoptosis that protect mice from acute liver failure.
Journal: Cell death & disease
Published: January 12, 2016
Last Updated: 09/26/2026